Olema Pharmaceuticals, Inc. - Common Stock (NQ:OLMA)

Olema Pharmaceuticals Inc. (NASDAQ: OLMA) Near the Top of Equities by Percentage Gain on 2/1

February 01, 2024

Eaton Posts Strong Results, Joins Ferrari, Boot Barn And Other Big Stocks Moving Higher On Thursday

February 01, 2024

U.S. stocks traded higher, with the Dow Jones gaining over 100 points on Thursday.

Via Benzinga

Topics Stocks

Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 11/28

November 28, 2023

Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 11/13

November 13, 2023

Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 11/9

November 09, 2023

Olema Oncology Nominates OP-3136, an Orally Bioavailable KAT6 Inhibitor, as a Development Candidate

January 08, 2024

Between buyouts, obesity drugs and neuroscience progress, biotech stocks stand to gain.

Eli Lilly, Crispr, Biogen Lead Pharma And Biotech Stocks To Great Expectations In 2024

January 05, 2024

Via Investor's Business Daily

Olema Oncology to Present at 42nd Annual J.P. Morgan Healthcare Conference

January 02, 2024

Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 11/8

November 08, 2023

Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 11/7

November 07, 2023

Olema Pharmaceuticals Inc. (NASDAQ: OLMA) is a Stock Spotlight on 10/16

October 16, 2023

Although U.S. stocks closed mostly higher on Monday, there were a few notable insider trades.

$6.9M Bet On This Healthcare Stock? Check Out These 4 Stocks Insiders Are Buying

December 19, 2023

Via Benzinga

Insiders Buying Walt Disney And 3 Other Stocks

December 11, 2023

Although U.S. stocks closed higher on Friday, there were a few notable insider trades.

Via Benzinga

Olema Oncology Announces Palazestrant Demonstrates Attractive Combinability with CDK4/6 Inhibitors Ribociclib and Palbociclib in Phase 1b/2 Studies

December 05, 2023

Analyst Ratings for Olema Pharmaceuticals

October 11, 2023

Via Benzinga

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 04, 2023

Olema Oncology to Present New Palazestrant Clinical Data in Combination with CDK4/6 Inhibitors at the 2023 San Antonio Breast Cancer Symposium (SABCS)

November 28, 2023

The company is working on treatments for breast cancer in a market worth $15 billion, according to the CEO.

12 Health Care Stocks Moving In Monday's Pre-Market Session

November 27, 2023

Via Benzinga

Olema Stock Has Soared 551% This Year. Its CEO Thinks It's Still Undervalued.

November 22, 2023

Via Investor's Business Daily

Olema Oncology Reports Third Quarter 2023 Financial Results and Provides Corporate Update

November 07, 2023

TreeHouse Foods, EchoStar, Hilton Grand Vacations, EchoStar And Other Big Stocks Moving Lower On Monday

November 06, 2023

U.S. stocks traded higher, with the Dow Jones gaining around 25 points on Monday. Here are some big stocks recording losses in today’s session.

Via Benzinga

Topics Stocks

Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 02, 2023

Olema Oncology to Participate in Upcoming Investor Conferences in November

November 01, 2023

Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for Palazestrant

October 22, 2023

U.S. stocks traded lower, with the Dow Jones falling around 50 points on Tuesday. Here are some big stocks recording gains in today’s session.

Wyndham Hotels & Resorts, Olink Holding And Other Big Stocks Moving Higher On Tuesday

October 17, 2023

Via Benzinga

Topics Stocks

Olema Oncology Appoints Oncology Biotech Executive Scott Garland to Board of Directors

October 17, 2023

Mr. Garland brings significant industry expertise with a long track record of successful launches

Olema Oncology Announces Phase 2 Monotherapy Clinical Results to be Presented at the 2023 ESMO Congress

October 16, 2023

Preclinical data to be presented at the 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Olema Oncology KAT6 Inhibitor Compounds Demonstrate Potent Anti-Tumor Activity

October 12, 2023

Olema Oncology Announces Expansion of Collaboration Agreement with Novartis

October 10, 2023